Private Equity
Capital Markets Seminar
26 September 2022
Agenda and introduction
Simon Borrows
Chief Executive
Agenda
14.00- | Agenda and introduction | Simon Borrows |
14.10 | Chief Executive | |
14.10- | BoConcept | Boris Kawohl |
14.50 | Q&A | Partner, Managing Director Benelux, Head of Consumer |
14.50- | Healthcare sector update | Richard Relyea |
15.30 | and Cirtec Medical | Partner, Managing Director North America, Head of Healthcare |
Q&A | ||
15.30- | WilsonHCG | Rahul Lulla |
16.10 | Q&A | Partner, North America |
16.10- | Closing remarks and | Simon Borrows |
16.30 | final questions | Chief Executive |
3
Portfolio update
- Investment portfolios continue to make good progress in challenging markets
- Private Equity portfolio:
- Assets in value for money consumer, healthcare, specialty industrial and business and technology services have generated strong earnings growth and have good momentum as we head into H2 FY23. We also see sustained increase in demand across travel related assets in the portfolio
- Assets exposed to discretionary spending continue to see headwinds, but encouraged by pricing power shown by a number of the more challenged companies, as well as ability to use other levers to partially mitigate inflation impacts
- Action's impressive performance continues with very strong sales and EBITDA growth; significant new customer flow driven by very low prices and good product availability
- YTD sales at over €5.8bn are over 26% ahead of the same period last year
- Expect LTM EBITDA to the end of P9 to be c.€1,035m compared to €765m at September last year and €506 million at September 2019
- Continued strong cash generation with net debt now standing at less than 2.1x run-rate EBITDA
- 142 new stores opened to date in 2022; on track to open more new stores in 2022 than in 2021
- Energy costs for 2022 estimated to total less than 0.4% of sales
- International investments (non-sterling) account for 87% of 3i's investment portfolio
4
Today's seminar
2016
Urban living designer
2021
Global winner in talent solutions
2017
Outsourced medical device manufacturing
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
3i Group plc published this content on 26 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 September 2022 12:34:04 UTC.